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Mengkaji keberkesanan dan perbezaan di antara Kataria dan Paedfusor model 
iaitu dua model pembiusan am menggunakan ubat propofol secara infusi kawalan 
sasaran semasa dan sejurus selepas pembiusan bagi kanak-kanak yang menjalani 
pembedahan elektif. 
 
ABSTRAK  
 
Latar belakang: Kataria dan Paedfusor adalah 2 model pembiusan am yang 
menggunakan ubat propofol secara infusi kawalan sasaran yang diiktiraf 
penggunaannya untuk tujuan pembiusan kanak-kanak. Tujuan kajian ini adalah untuk 
mengkaji keberkesanan dan perbezaan di antara model-model ini untuk pembiusan 
kanak-kanak yang menjalani pembedahan elektif. 
 
Tatacara: 38 pesakit berumur 3 hingga 12 tahun yang mempunyai tahap kesihatan yang 
baik (ASA I atau II), menjalani pembedahan secara elektif dengan kaedah pembiusan 
penuh, dibahagikan secara rawak kepada 2 kumpulan: kumpulan Kataria (n=19) dan 
kumpulan Paedfusor (n=19). Semua pesakit diberikan infusi remifentanil pada dos 
1mcg/kg selama 1 minit 15 saat diikuti infusi pada kadar 0.1 hingga 1mcg/kg/min. 
Kemudian, kedua-dua kumpulan dimulakan dengan infusi kawalan sasaran ubat 
propofol pada target konsentrasi plasma 6 mcg/ml menggunakan model kumpulan 
masing-masing semasa induksi dan ikuti pada target konsentrasi plasma 3 hingga 6 
mcg/ml berdasarkan bacaan BIS semasa pembedahan. Masa untuk induksi, masa untuk 
pesakit sedar dan konsentrasi plasma ubat propofol ketika pesakit sedar direkodkan bagi 
tujuan analisis. 
viii 
 
 
Keputusan: Kedua-dua kumpulan berjaya dibiuskan oleh model infusi kawalan sasaran 
dengan target konsentrasi plasma 6 mcg/ml. Tiada perbezaan di antara kedua model 
untuk masa induksi dan masa yang di ambil untuk bangun. Target konsentrasi plasma 
bagi kumpulan Kataria lebih rendah berbanding kumpulan Paedfusor [1.48 (0.11) minit 
vs 1.59 (0.14) minit, p=0.01]. 
 
Kesimpulan:  Kedua-dua model infusi kawalan sasaran terbukti keberkesanannya dalam 
pembiusan. Tiada perbezaan masa yang diambil untuk induksi dan masa pesakit sedar. 
Didapati target konsentrasi plasma kumpulan Kataria lebih rendah. 
 
Kata kunci: Kataria model, Paedfusor model, infusi kawalan sasaran, propofol, 
remifentanil. 
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Comparison of the effectiveness between Kataria and Paedfusor models of Target-
controlled Infusion (TCI) during anaesthesia in elective paediatric surgery. 
 
Abstract  
 
Background: Kataria and Paedfusor are two validated target controlled infusion (TCI) 
models for propofol in paediatric population.  The aim of this study was to compare the 
effectiveness of these two different TCI models for propofol in paediatric age group 
during elective surgery. 
 
Methods: 38 patients, aged 3-12 year-old, classified under ASA I and II, who 
underwent elective surgery under general anaesthesia, were randomised into two 
groups; Group Kataria (n=19) and Group Paedfusor (n=19).  All patients received 1 
mcg/kg loading dose of intravenous (IV) remifentanil over 1 minute 15 seconds and 
followed with infusion at 0.1 to 1 mcg/kg/min.  Then, both groups were induced at 
plasma concentration (Cpt) propofol of 6 mcg/ml using respective model and 
maintained with Cpt between 3 to 6 mcg/ml guided by bispectral index (BIS) between 
40-60.  Remifentanil was maintained between 0.1 to 1 mcg/kg/min. Success rate of 
induction, induction time, recovery time and plasma concentration (Cp) at recovery 
were recorded for statistical analysis. 
 
Results: Both groups were successfully induced with propofol Cpt of 6mcg/ml.  There 
were no significant difference in induction and recovery time between these two groups. 
The plasma concentration at recovery in Kataria group was significantly lower than 
Paedfusor group [1.48 (0.11) mcg/ml vs 1.59 (0.14) mcg/ml, p=0.01]. 
x 
 
Conclusion: TCI propofol for paediatric patients using Kataria and Paedfusor models 
were equally effective in success rate of induction, induction time and recovery time. 
Only plasma concentration at recovery was lower in Kataria group. 
 
Keywords: Kataria model, Paedfusor model, propofol, remifentanil, target-controlled 
infusion. 
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SECTION 1 
INTRODUCTION 
 
1.0 Introduction 
Total intravenous anaesthesia (TIVA) is a method of anaesthesia using only 
intravenous anaesthetic drugs. It can be delivered either in a conventional technique or 
in target controlled infusion (TCI) technique. TCI is a method of delivering intravenous 
(IV) drugs using a special infusion pumps which is incorporated with software consisted 
of a pharmacokinetics algorithm of the specific drugs .The properties of the drugs that 
are currently capable to be delivered by TCI methods are; fulfill the three 
compartmental models in distribution, short context-sensitive half-life and rapid in 
clearance. The only drugs that have validated pharmacokinetic models for TCI in adult 
at the moment are propofol and remifentanil [1]. 
Propofol is a substituted isopropylphenol (2,6-diisopropylphenol) that is 
administered intravenously as 1% solution in an aqueous solution of 10% soybean 
oil,2.25% glycerol, and 1.2% purified egg phosphatide (Figure 1) . This drug is 
chemically distinct from all other drugs that act as intravenous sedative-hypnotics. 
Administration of propofol, 1.5 to 2.5 mg/kg as a rapid injection (<15 sec), produces 
unconsciousness within about 30 seconds. Propofol is presumed to exert its sedative-
hypnotic effects through a GABAᴀ receptor interaction. The interaction of propofol 
with specific components of GABAᴀ receptors appears to decrease the rate of 
dissociation of the inhibitory neurotransmitter, GABA from the receptor, thereby 
increasing the duration of the GABA-activated opening of the chloride channel with 
resulting hyperpolarization of cell membrane [2]. 
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Figure 1: Structure of propofol (source: JAnaesth Clinical Pharmacology, 2011) 
Propofol metabolism in humans is considered to be both hepatic and 
extrahepatic. Hepatic metabolism is rapid and extensive, resulting in inactive, 
watersoluble sulphate and glucuronic acid metabolites that are excreted by the kidneys. 
The fact that total body clearance of propofol exceeds hepatic blood flow is consistent 
with extrahepatic clearance (pulmonary uptake and first pass elimination, renal 
excretion) of propofol [3]. The context-sensitive half-time (CSHT) for propofol 
infusions lasting up to 8 hours is <40 minutes. The CSHT of propofol is minimally 
influence by the duration of the infusion because of rapid metabolic clearance when the 
infusion is discontinued [4]. This characteristic makes it suitable for TIVA. In addition, 
the general anaesthesia by propofol associated with minimal postoperative nausea 
vomiting, and awakening is prompt, with minimal residual sedative effect.  
Nowadays, propofol is the commonest intravenous agent that has been used for 
induction and maintenance of anaesthesia, procedural and critical care sedation in 
children. In 1989, Federal Drugs and Administration (FDA) approved the use of 
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propofol for maintenance of anaesthesia in children 2 months old and above and for 
induction of anaesthesia in children 3 years old and above. The use of propofol for 
induction of anaesthesia in children less than 3 years old still remains off-label [4].  
Remifentanil is a selective mu opiod agonist, short acting phenylpiperidine 
derivatives. Remifentanil is structurally unique because of ester linkage (Figure 2). This 
structure renders it susceptible to hydrolysis by nonspecific plasma and tissue esterases 
to inactive metabolites. This unique pathway of metabolism imparts to remifentanil 
brevity of action, precise and rapidly titratable effect due to its rapid onset and offset, 
noncumulative effects and rapid recovery after discontinuation of its administration. 
The pharmacokinetics of remifentanil are characterized by small Vd, rapid clearance 
and low interindividual variability compared to other IV anaesthetic drugs . CSHT for 
remifentanil is independent of the duration of infusion and is estimated to be about 4 
minutes [5]. The combination of rapid clearance and small Vd responsible for the lack 
of accumulation even during prolonged periods of infusion. The facts that remifentanil 
has rapid clearance and rapid blood-brain equilibration, the changes infusion rates will 
be paralleled by changes in drug effect [5]. All these characteristics make it suitable for 
TIVA / TCI. Its rapid and consistent metabolism regardless of duration of infusion has 
made remifentanil a good choice for analgesia/anaesthetic option for paediatric care 
provider. Remifentanil has a CSHT that remains constant even in smaller children and 
neonates, which unique in paediatric practice [6].  
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Figure 2: Structure of remifentanil (Source: PubChem, 2005) 
TCI technique has been well established in adult patients for the past 15 years. 
In adult, pharmacokinetic models that can be used for TCI propofol is either Marsh or 
Schneider model whereas the only model can be used for TCI remifentanil is Minto 
model. The only validated paediatric models for TCI propofol are Kataria and Paedfusor 
models. TCI technique is different from conventional TIVA where it requires the user to 
set target plasma concentration or target-effect concentration of the drugs (the 
concentration of the drug at the brain level) that is aimed to be achieved based on key in 
data of patient’s age, body weight, height and gender. Whereas, the conventional TIVA 
requires us to calculate the infusion rate based on the recommended dosage of the drugs 
[1]. 
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In general, inhalational anaesthesia technique has been more common practice 
of general anaesthesia in paediatric for quite sometimes and it is still the more familiar 
technique nowadays. However, there are list of the surgeries or procedures that have 
more advantages of using TIVA/TCI technique than inhalational anaesthesia technique. 
Indications for TIVA/TCI in children: 
 Children undergoing frequent, repeated anesthesia (e.g.: radiation therapy) 
 Brief radiologic or painful procedures where rapid recovery is needed (e.g. MRI, 
bone marrow aspiration, gastrointestinal endoscopy). 
 During major surgery to control the stress response. 
 During neurological procedures to assist with control of intracranial pressure 
and for cerebral metabolic protection. 
 During spinal instrumentation surgery to provide controlled hypotension and 
when there is a need for evoked motor and auditory brain potentials or 
intraoperative wake-up test 
 During airway procedures (e.g. bronchoscopy) 
 Children at risk of malignant hyperthermia 
 Children with increased risk of postoperative nausea and vomiting. 
The advantages of TIVA/TCI over inhalational anaesthesia in paediatric: 
 Induction is very rapid in onset 
 Large keo in children result in very quick induction and rapid equilibration 
between plasma and effect site 
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 Rapid onset of action independent from alveolar ventilation 
 Improved quality of emergence from anaesthesia 
 Very smooth and peaceful recovery 
 No risk of environment pollution 
 Reduction in the incidence of postoperative nausea and vomiting 
 Increased patient comfort, parental satisfaction in the postoperative period 
 Propofol reduces brain metabolism and cerebral blood flow, hence used in 
reduction of intracranial pressure 
 Method of choice in patients at risk of malignant hyperthermia 
 Method of choice in some patients with congenital myopathies 
 Useful method for spinal surgery using motor evoke potential (MEP) or 
somatosensory evoked potential (SSEP) monitoring because propofol does not 
suppress the wave form 
 Can be reliably administered to maintain anaesthesia in patients undergoing 
airway procedures [1]. 
A three compartment model can be used to mathematical describe the behaviour 
of most anaesthetic drugs with reasonable accuracy (Figure 3).Central compartment,V1 
is referred to as initial volume of distribution in which the drug is delivered and 
eliminated from a central compartment. In children, the volume of distribution are 
larger than adults. Hence, they need higher dose of drug for induction of anaesthesia. 
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The drug also distributes to and redistributes from two peripheral compartments, V2 
representing well-perfused organs and tissues also called fast redistribution 
compartments. And V3 referred to as the vessel poor or slow compartment. The sum of 
V1,V2 and V3 gives the volume of distribution at steady state (Vdss). The rate of 
transfer between compartments and elimination can be describes using rate constants. 
By convention, k10 means rate constant for elimination, whereas k12,k21,k13 and k31 
are used to denotes the rate constants for transfer between V1 and V2,V2and V1 and V1 
and V3 and between V3 and V1 respectively. The term keo describes the rate of 
removal of drug from the effect site.keo is derived from Pk and Pd parameters from a 
study population. The other parameter t1/2keo is 0.693/keo is sometimes used to 
express this rate constant [1].
Figure 3: Schematic representation of  a three compartment model  (source:  
docslide.com). 
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The Pk concepts related to TIVA/TCI in children are differ from adults. Healthy 
children need a relatively high dose intravenous agent per unit of body weight and 
maintanance infusions rates need to be higher than the weight corrected dose for adult. 
This is because there are changes in regional blood flow, body composition, and body 
proportion in children. The clearance is very high in children, hence they need a higher 
maintenance infusion rate at steady state. At the age of 3 to 11 years old, the volume of 
distribution Vd is 9700mls/kg and clearance is 34ml/min/kg. Whereas in adult Vd is 
4700ml/kg and clearance is 28ml/min/kg [1]. That is why adults TCI pump cannot be 
used in paediatric age group. 
There are 2 validated TCI models in paediatric population which are Kataria and 
Paedfusor. The Paedfusor system was developed in the early 1990s as a variant of the 
Diprifusor (adult TCI software). The lower age limit for the use of Paedfusor is 1 year 
and the lower weight limit is 5 kg. Another validated TCI model for paediatric is 
Kataria model. This model was developed from the study over 600 plasma propofol 
samples from 53 children at various stages of induction, maintenance and recovery from 
anaesthesia. The lower age limit for the use of Kataria model is 3 years and the lower 
weight limit is 15kg (7). The two models of TCI are differ in PK profile. A study done 
by Munoz et al, in children aged 3-11,derived keo (keo is rate of removal of drug from 
the effect site) values for the Paedfusor model of 0.91/min (t1/2keo 0.8 min) and for 
Kataria models of 0.41/min (t1/2keo 1.7min) (8) . Table 1 summarizes the differences of 
PK between Kataria and Paedfusor for a 6 years old child, 20kg [9]. 
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 Kataria 
 
 
Paedfusor 
 
 
   
 
 
 
V1 (L) 
 
7.6 
 
9.2 
 
 
           V2 (L)             17.4             19 
 
 
           V3 (L)             122.34             117.1 
 
 
Cl 1 L/min 
 
Cl 2 L/min 
0.74 
 
1.26 
0.58 
 
1.05 
 
 
            Cl 3 L/min                          0.5 0.39 
 
 
 
            K10/min 
 
K12/min 
 
K13/min 
 
K21/min 
             
           K31/min 
            0.097 
 
0.166 
 
0.066 
 
0.072 
 
0.0041 
0.063 
 
0.114 
 
0.042 
 
0.055 
 
0.0033 
 
 
 
From the data,we can see that the clearance and redistribution  in Kataria model 
are faster than  Paedfusor model. These Pk differences might lead to difference in 
clinical performance between this two group of TCI model. There was a study done by 
Coppen et al tested the performance of eight TCI models including Kataria and 
Paedfusor in heathy children from 3 to 26 months age. The study shown Kataria model 
performs poorly (Pk performance :MDPE 31.3%, MDAPE 34.1%) compared to 
Paedfusor model (MDPE 10.4% and MDAPE 19%) [10]. However, the study was 
performed in children less than 3 years old and the accuracy of models were measured 
based on the plasma concentration from arterial blood sampling. From our literature 
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search, there was no study previously comparing the clinical effectiveness between 
these two models. Our aims of the study are to compare the effectiveness of these two 
models during induction and recovery of anaesthesia. 
Several factors that influence the patients selection in this study. The main 
factors are Pk and Pd of propofol. In this study, paediatric age group 3 to 12 years old 
was choosen because its fullfill the criteria for Kataria ( for paediatric age 3 to 16 years 
old) and Paedfusor model ( for paediatric age 1 to 16 years old). The other reason is to 
minimize the interindividual variability. This is because from birth to the age of 
15,many changes influence Pk and metabolism. Three periods may be distinguisehed, 
the neonate, the infant and the prepubertal children. During neonatal period, anaesthetic 
doses have to be decreased to reach and maintain a target concentration because global 
immaturity and increased sensitivity to anaesthetic drugs. In infants (two-years of life), 
characterized by wide inter and intra variability  because of progressive increase in 
distribution volume and fast maturational increase in clearance. From 3 years to 
puberty, volumes are nearly twice greater and inter-compartmental clearance 50% 
greater than adult [9].  
The subjects of this study must be healthy children (ASA 1 and ASA 2) since 
the effects of propofol particularly to the cardiovascular system. Propofol can cause 
bradycardia and hypotension produced by inhibition of symphathetic vasoconstrictor 
nerve activity and negative inotropic effect [11] . The patients with heart disease are 
excluded in this study because they might not tolerate with this cardiovascular changes. 
Bispectral index (BIS) was used in this study to monitor depth of anaesthesia. Its 
prevent overuse of propofol and avoid awareness during anaesthesia. The BIS reading 
should be maintained between 40 to 60 for anaesthesia. A study done by Agnes et al, 
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regarding the relationship between BIS and propofol during TCI anaesthesia 
comparison between prepubertal subjects and young adults, concluded that good 
relationship between propofol concentration and BIS in children as in adult [12]. In 
children, the predictibility of plasma propofol concentration with the classical Pk/Pd 
model is limited. Therefore, a cerebral Pd feedback, such as BIS may be useful in this 
population . 
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1.1 Rationale of Study 
This study was to compare the effectiveness of Kataria and Paedfusor TCI models in  
providing anaesthesia in paediatric age group. This study was focus on successful rate 
of induction with TCI propofol 6 mcg/ml, induction time, and time of recovery and 
plasma concentration of propofol during recovery. Up to now, there was no study done 
to determine the effectiveness of Kataria TCI model and comparing Kataria and 
Paedfusor TCI models. This research is necessary to determine which one is the most 
effective between these 2 validated TCI models in paediatric population. 
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SECTION 2 
OBJECTIVES OF THE STUDY 
 
2.1 Primary objectives:  
 To compare the effectiveness of Kataria versus Paedfusor models of target 
controlled infusion (TCI) propofol during anaesthesia for paediatric patients.  
 
2.2 Secondary objectives: 
 To compare the success rate of induction at initial induction target plasma 
concentration of 6 mcg/ml between the two models. 
 To compare the induction time between the two models at target plasma 
concentration of 6 mcg/ml  
 To compare plasma concentration at emergence between the two models 
 To compare the time of recovery during emergence between the two models. 
 
 
 
 
 
 
 
 
 
 
14 
 
SECTION 3 
BODY CONTENT 
3.1 Title page 
Title:  
Comparison of the Effectiveness between Kataria and Paedfusor Models of 
Target-Controlled Infusion (TCI) during Anaesthesia in Elective Paediatric 
Surgery. 
 
Short title:  
Comparison of Kataria and Paedfusor Models of Target-controlled Infusion Propofol  
in Paediatric Anaesthesia. 
 
Authors’ names and institutional affiliation: 
1. Azelia binti MANSOR 
Department of Anaesthesiology, School of Medical Sciences, Jalan Sultanah 
Zainab II, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan 
2. Wan Mohd Nazaruddin WAN HASSAN 
Department of Anaesthesiology, School of Medical Sciences, Jalan Sultanah 
Zainab II, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan 
3. Nik Abdullah NIK MOHAMAD 
Department of Anaesthesiology, School of Medical Sciences, Jalan Sultanah 
Zainab II, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan 
4. Rhendra Hardy MOHAMAD ZAINI 
Department of Anaesthesiology, School of Medical Sciences, Jalan Sultanah 
Zainab II, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan 
15 
 
Corresponding author: 
Azelia binti Mansor, MBBS 
Department of Anaesthesiology, School of Medical Sciences, Jalan Sultanah Zainab II, 
Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan. 
Tel no: +60194028264 
Fax no: +6097653000 
Email: azeliamansor82@yahoo.com 
 
Conflict of interest: None 
 
Acknowledgement:  
I would like to acknowledge Miss Faza Ayunnie for her assistance on statistical 
analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
16 
 
3.2 Main document 
Title:  
Comparison of the Effectiveness between Kataria and Paedfusor Models of 
Target-Controlled Infusion (TCI) during Anaesthesia in Elective Paediatric 
Surgery. 
 
Abstract 
Background: Kataria and Paedfusor are two validated target controlled infusion (TCI) 
models for propofol in paediatric population.  The aim of this study was to compare the 
effectiveness of these two different TCI models for propofol in paediatric age group 
during elective surgery. 
 
Methods:  38 patients, aged 3-12 year-old, classified under ASA I and II, who 
underwent elective surgery under general anaesthesia, were randomised into two 
groups; Group Kataria (n=19) and Group Paedfusor (n=19).  All patients received 1 
mcg/kg loading dose of intravenous (IV) remifentanil over 1 minute 15 seconds and 
followed with infusion at 0.1 to 1 mcg/kg/min.  Then, both groups were induced at 
plasma concentration (Cpt) propofol of 6 mcg/ml using respective model and 
maintained with Cpt between 3 to 8 mcg/ml guided by bispectral index (BIS) between 
40-60.  Remifentanil was maintained between 0.1 to 1 mcg/kg/min. Success rate of 
induction, induction time, recovery time and Cpt at recovery were recorded for 
statistical analysis. 
 
Results: Both groups were successfully induced with propofol Cpt of 6 mcg/ml.  There 
were no significant differences in induction and recovery time between these two 
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groups. The plasma concentration at recovery in Kataria group was significantly lower 
than Paedfusor group [1.48 (0.11) mcg/ml vs 1.59 (0.14) mcg/ml, p=0.01]. 
 
Conclusion:  TCI propofol for paediatric patients using Kataria and Paedfusor models 
were equally effective in success rate of induction, induction time and recovery time. 
Only plasma concentration at recovery was lower in Kataria group. 
 
Keywords:  Kataria model, Paedfusor model, propofol, remifentanil, target-controlled 
infusion. 
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Introduction  
Total intravenous anaesthesia (TIVA) is a method of anaesthesia using only 
intravenous anaesthetic drugs.  It can be delivered either in a conventional technique or 
on target controlled infusion (TCI) techniques.  TCI is an advanced method of 
delivering intravenous (IV) drugs using a special infusion pump which is incorporated 
with software consisted of an algorithm based on pharmacokinetics (PK) profile of the 
specific drugs and age appropriate parameters.  The properties of the drugs that are 
currently capable to be delivered by TCI methods are; fulfill the three compartmental 
models in distribution, short context-sensitive half-life and rapid in clearance. The only 
drugs that have validated pharmacokinetic models for TCI at the moment are propofol 
and remifentanil [1]. 
The PK concepts related to TIVA/TCI in children are differ from adults.  
Healthy children need a relatively high dose intravenous agent per-unit of body weight 
and maintenance infusions rates need to be higher than the weight corrected dose for 
adults.  This is because there are changes in regional blood flow, body composition, and 
body proportion of children.  The clearance is very high in children. Hence, they need a 
higher maintenance infusion rate at steady state.  At the age of 3 to 11 years old, the 
volume of distribution (Vd) is 9700mls/kg and clearance is 34ml/min/kg. Whereas in 
adult Vd is 4700ml/kg and a clearance is 28ml/min/kg [1].  That is why adults TCI 
models cannot be used in paediatric age group.  
There are 2 validated TCI models in paediatric population, which are Kataria 
and Paedfusor.  The Paedfusor system was developed in the early 1990s as a variant of 
the Diprifusor (adult TCI software).  The lower age limit for the use of Paedfusor is 1 
year and the lower weight limit is 5 kg.  Another validated TCI model for paediatric is 
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Kataria model.  This model was developed from the study over 600 plasma propofol 
samples from 53 children at various stages of induction, maintenance and recovery from 
anaesthesia. The lower age limit for the use of Kataria model is 3 years and the lower 
weight limit is 15kg [2]. 
The two models of TCI differ in PK profile. A study done by Munoz et al, in 
children aged 3-11, derived keo (keo is the rate of removal of drug from the effect site) 
values for the Paedfusor model of 0.91/min (t1/2keo 0.8 min) and for Kataria models of 
0.41/min (t1/2keo 1.7min) [3]. Other differences are initial volume of distribution, 
Paedfusor: 9.2L whereas Kataria: 7.6L, clearance in Paedfusor: 0.58L/min whereas 
Kataria: 0.74L/min [4].  Although there are differences between these two TCI models, 
both are validated and performed well clinically. 
From our literature search, there is no study at the moment comparing the 
effectiveness between these two models.  Our aims are to compare the effectiveness of 
these two models during induction and recovery of anaesthesia.  
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Materials and Methods 
This study was a prospective, double-blinded, randomised controlled trial, conducted in 
the university hospital (Hospital Universiti Sains Malaysia). 
After approval from the university ethics committee and written inform consent 
from all patient’s parents, 38 patients undergoing elective surgery under general 
anaesthesia, with age between 3 to 12 years old and American Society of 
Anaesthesiologists (ASA) class I-II, were randomized into two groups; Group Kataria 
(n=19) and Group Paedfusor (n=19).  Those patients with a history of allergies to study 
drugs, co-morbidities related to the heart and history of inborn error metabolism of lipid 
which are risky for propofol infusion syndrome were excluded from the study.  Patients 
were withdrawn from the study if not cooperative during intravenous line insertion, 
severe hypotension or bradycardia after starting infusion of study drugs that required 
optimisation with rescue drugs (atropine/ ephedrine). 
 
 Randomisation 
A study number of 01 to 38 was prepared.  These numbers were being labelled 
as Group A (Kataria) or Group B (Paedfusor) and the randomization was done through 
the internet, at the website of www.randomization.com. 38 subjects were randomised 
and divided into 2 groups equally, Group A (Kataria) and Group B (Paedfusor).  The 
study was completed after 38 patients successfully recruited. Initial 38 subjects for 
randomisation were based on a calculation of a 10 % drop out rate. 
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Blinding  
This study was a double blinded study where the patient and the second medical 
officer who assessed the patient in the OT did not know which model of TCI propofol 
was being used.  All patients used a standard Alaris™ PK TCI pump for TCI propofol 
and manual infusion pump for remifentanil.  TCI pump setting up was performed by 
anaesthesiology registrar based on randomisation.  The conduct of anaesthesia was 
performed by a second medical officer and data collection was done by the first 
investigator. 
 
Study protocol 
After approval from Ethics committee, patients were selected according to inclusion 
and exclusion criteria during the preoperative assessment round.  Study procedures were 
explained and written consents were obtained from parents.   In all children, eutectic 
mixture of local anesthetic cream was applied on both hands during pre-operative visit 
and intravenous (IV) cannula was inserted after an hour in the ward.  No premedication 
was prescribed in the morning of the surgery.  All consented patients were randomized 
using computer generated randomization into two groups:  Group A (Kataria model) 
and group B (Paedfusor model).  In OT, all of the patients monitored for non-invasive 
blood pressure, pulse oxymeter, electrocardiogram, capnography and bispectral index 
monitoring (BIS). After pre-oxygenation for 3 minutes, all patients received a slow 
bolus of intravenous infusion of remifentanil 1 mcg/kg for 1 minute 15 seconds as 
initial analgesia.  During induction, Group A was induced with the Kataria model of 
TCI propofol at 6 µg/ml, whereas Group B was induced with a Paedfusor model of the 
TCI propofol also at Cpt of 6 µg/ml.  After successful induction, the supraglottic device 
(laryngeal mask airway) was inserted to aid the respiration.  The subject was breathing 
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spontaneously throughout the surgery.  During the maintenance of anaesthesia, both 
groups were maintained at target plasma concentration propofol of 3-8 µg/ ml with 
either using Kataria model in group A or Paedfusor model in group B and were guided 
with BIS index of 40-60. All patients received continuous infusion of remifentanil 0.1-
1.0 µg/kg/min as main intraoperative analgesia.  Supplement analgesia was provided 
appropriately with suppository paracetamol 20 mg/kg and/or suppository diclofenac 
sodium 1 mg/kg.  The regional block was given to patients if no contraindication.  After 
completion of the surgical procedure, TCI propofol and remifentanil infusion were 
discontinued and patients were extubated when they were fully recovered.   The success 
rate of induction at Cpt of 6 μg/ml, induction time, plasma concentration at recovery 
and the recovery time were recorded.  The success rate of induction was defined as 
successful loss of consciousness and verbal response at initial Cpt.  The induction time 
was defined as the time taken from starting of infusion of propofol to loss of 
consciousness/verbal response. The plasma concentration at recovery was defined as the 
concentration of propofol at the plasma level, which was displayed on the TCI pump 
monitor at extubation. The recovery time was defined as the time taken from 
discontinuation of propofol to extubation. 
Sample size calculation 
The sample size calculation was based on the study by Agnes Rigouzzo which resulted 
a significant difference in time of emergence was 0.4, standard deviation 0.35 with a 
power of 0.8 and α=0.05 [5]. The calculated sample size was 17 per group.  We used 
Power and Sample size software version 3.0.10 for the calculation version 3.1.2. After 
considered 10% drop out.  Therefore, the total samples were 38 patients. 
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Statistical analysis 
All measurement data were analysed for normal distribution and homogeneity 
variance.  Measurement of data that showed a normal distribution was presented as 
mean (standard deviation). The non-normal distribution was presented as median. 
Variables between groups were analysed with independent tests. The statistical analysis 
was performed by SPSS version 22 software and P < 0.05 was considered as a 
significant difference.  
 
Results 
38 patients were enrolled in the study, with 19 patients in Group Kataria and 
another 19 patients in Group Paedfusor. The types of surgery underwent by the study 
subjects included general surgery (84.2%) and orthopaedic surgery (15.8%). There was 
no significant difference in terms of age, height, weight, genders, types of surgery and 
ASA health status between the two study groups (Table 1). 
All study subjects were successfully induced with TCI propofol at Cpt 6 mcg/ml. There 
was no significant difference in time of successful induction between the two groups 
(Table 2).  There was also no significant difference in time of recovery.  In terms of 
plasma concentration of propofol at emergence, there were differences between the two 
groups  (Table 2) in which Kataria group was significantly lower than Paedfusor group 
[1.48 (0.11) mcg/ml vs 1.59 (0.14) mcg/ml, p=0.01]. 
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Discussion  
Total intravenous anaesthesia (TIVA) has become more popular and possible in recent 
times because of the PK and pharmacodynamics properties of propofol and the 
availability of short acting opioids such as remifentanil.  The propofol anaesthesia has 
been especially focused on TCI anaesthesia taking into account its well known 
advantages in adults. A study done by Russel et al comparing manual infusion with TCI 
propofol in adult shown that more rapid induction and haemodynamic stability in TCI 
group [6].  
 A UK survey on paediatric total intravenous use revealed that about 25% of 
paediatric anaesthetists use TIVA at least monthly, 40% rarely and the remaining 
anaesthetists never. Over the last year 13% of anaesthetists used TIVA in children under 
1 year of age, and the two most common surgical specialties with which TIVA used are 
ENT and orthopaedics. Lastly, TCI is still uncommonly used in children [7]. 
Eventhough it was the only European survey, it highlights that TIVA and TCI is still not 
a common practice for paediatric anaesthetist, but they perceive the anaesthetic and 
surgical benefits. The recent knowledge on Pk in childhood together with sophisticated 
devices have increased the perception of TIVA safety.  
 The Kataria and Paedfusor were validated TCI models in paediatric population.  
The Alaris Pk is a commercially available infusion pump that has both Kataria and 
Paedfusor TCI models that can be chosen by the user for induction and maintenance of 
anaesthesia.   An algorithm based on population pharmacokinetics, patient’s age and 
weight was used to estimate plasma concentrations of propofol and adjusted the 
infusion rate to achieve a set target.  In the adult devices, to achieve rapid induction, 
improvement has been made to target directly on the effect site. This approach required 
the knowledge of the rate constant called ke0 between plasma and effect site.  In 
